Pharmacy news
Commercial drug coverage changes coming for Tysabri and Revlimid
Commercial drug coverage changes coming for Tysabri and Revlimid
December 15, 2025
GLP-1 Weight-loss drug coverage changes coming for Medicaid members
Effective Jan. 1, 2026, coverage and criteria of GLP-1 weight-loss drugs Saxenda, Wegovy and Zepbound will become more restrictive for all Michigan Medicaid members.
December 15, 2025
Dalvance® to be removed from coverage in place of generic
Effective. Feb. 4, 2026, Dalvance® will be removed from medical drug coverage for commercial group and individual members and replaced with its generic, Dalbavancin.
December 1, 2025
OxyContin® to be removed from formulary Jan. 1, 2026
OxyContin® to be removed from formulary Jan. 1, 2026
November 21, 2025
Steqeyma and Starjemza added to coverage
Steqeyma and Starjemza added to coverage to ensure access of Stelara biosimilars
November 21, 2025
10/28/2025: Drug coverage changes coming Jan. 1, 2026
Drug coverage changes coming for select members
October 28, 2025
10/15/2025: IXCHIQ and Ocaliva withdrawn from market due to safety concerns
IXCHIQ and Ocaliva withdrawn from the market due to potential safety concerns
October 15, 2025
09/03/2025: We've improved our Medical Benefit Drug List
Updating the format of our MBDL
September 3, 2025
09/02/2025: Coverage changes coming for OneTouch® and Accu-Chek Guide testing supplies
Changes to coverage for some diabetic supplies
August 29, 2025
Recall of Sucralfate 1 gram tablets manufactured by Nostrum Laboratories, Inc.
Recall of Sucralfate 1 gram tablets manufactured by Nostrum Laboratories, Inc.
August 20, 2025
08/06/2025 Provider news: Medicare PA criteria updates take effect Oct. 1 for non-preferred hyaluronic acid products
Medicare PA criteria updates take effect Oct. 1 for non-preferred hyaluronic acid products.
August 6, 2025
Updates to Arine MTM faxes
Arine, our Medication Therapy Management (MTM) vendor, is updating how patient information is organized in MTM faxes.
July 8, 2025